Analyzing Illumina Gene Expression Microarray Data from Different Tissues: Methodological Aspects of Data Analysis in the MetaXpress Consortium
Year: 2012
Type: article
Abstract: Microarray profiling of gene expression is widely applied in molecular biology and functional genomics. Experimental and technical variations make meta-analysis of different studies challenging. In a total of 3358 samples, all from German population-based cohorts, we investigated the effect of data preprocessing and the variability due to sample processing in whole blood cell and blood monocyte gene expression data, measured on the Illumina HumanHT-12 v3 BeadChip array.Gene expression signal intensities were similar after applying the log(2) or the variance-stabilizing transformation. In all cohorts, the first principal component (PC) explained more than 95% of the total variation. Technical factors substantially influenced signal intensity values, especially the Illumina chip assignment (33-48% of the variance), the RNA amplification batch (12-24%), the RNA isolation batch (16%), and the sample storage time, in particular the time between blood donation and RNA isolation for the whole blood cell samples (2-3%), and the time between RNA isolation and amplification for the monocyte samples (2%). White blood cell composition parameters were the strongest biological factors influencing the expression signal intensities in the whole blood cell samples (3%), followed by sex (1-2%) in both sample types. Known single nucleotide polymorphisms (SNPs) were located in 38% of the analyzed probe sequences and 4% of them included common SNPs (minor allele frequency >5%). Out of the tested SNPs, 1.4% significantly modified the probe-specific expression signals (Bonferroni corrected p-value<0.05), but in almost half of these events the signal intensities were even increased despite the occurrence of the mismatch. Thus, the vast majority of SNPs within probes had no significant effect on hybridization efficiency.In summary, adjustment for a few selected technical factors greatly improved reliability of gene expression analyses. Such adjustments are particularly required for meta-analyses.
Source: PLoS ONE
Authors: Claudia Schurmann, Katharina Heim, Arne Schillert, Stefan Blankenberg, Maren Carstensen, Marcus Dörr, Karlhans Endlich, Stephan B. Felix, Christian Gieger, Harald Grallert, Christian Herder, Wolfgang Hoffmann, Georg Homuth, Thomas Illig, Jochen Kruppa, Thomas Meitinger, Christian Müller, Matthias Nauck, Annette Peters, Rainer Rettig, Michael Roden, Konstantin Strauch, Uwe Völker, Henry Völzke, Simone Wahl, Henri Wallaschofski, Philipp S. Wild, Tanja Zeller, Alexander Teumer, Holger Prokisch, Andreas Ziegler
Institutions: Universität Greifswald, Helmholtz Munich, Institut für Humangenetik, University Hospital Schleswig-Holstein, German Centre for Cardiovascular Research, University of Lübeck, Deutsches Diabetes-Zentrum e.V., Heinrich Heine University Düsseldorf, Universitätsmedizin Greifswald, Medizinische Hochschule Hannover, Technical University of Munich, Düsseldorf University Hospital, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, University Medical Center of the Johannes Gutenberg University Mainz
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: Deutsches Zentrum für Herz-Kreislaufforschung, European Commission, Deutsche Forschungsgemeinschaft, Agence Nationale de la Recherche, Bundesministerium für Bildung und Forschung, Bundesministerium für Gesundheit, Siemens, Universität Greifswald, Ministry of Cultural Affairs, Leibniz-Gemeinschaft, Helmholtz Zentrum München
Awards: Verbundprojekt: Spitzenforschung und Innovation in den Neuen Ländern - GANI_MED - Greifswald Approach to Individualized Medicine, Biomarker for Cardiovascular Risk Assessment in Europe, Anwendung von DNA-Array-Technologien in Molekularer Medizin und Mikrobiologie, G5165178750, G575173146, G5780152635, G5800340488, Verbundprojekt: Atherogenomics - Teilprojekt, A1, A2, B2, C2, D1, D2, F1: Identifizierung und Charakterisierung von Risikogenen für Herzinfarkt und coronare Herzkrankheit, Verbundkoordination, G6487764846, Verbundprojekt: Atherogenomics - Teilprojekt, A3, E2: Genomik und funktionelle Analysen subklinischer Phänotypen der Arteriosklerose, Evaluation eines SNP-Chips bezüglich koronarer Herzkrankheit und Diabetes, G7558636403, Verbundvorhaben: SysMBo - Systembiologie der metabolischen Phänotypen, TP A, Verbundprojekt: Atherogenomics - Teilprojekt, A3, D1: Genomik, funktionelle Analysen und Genexpressionsstudien bei subklinischen Phänotypen kardiovaskulärer Erkrankungen
OpenAlex ID: W2017101446
